Abstract

The human metapneumovirus (hMPV) fusion (F) protein is essential for viral entry and is a key target of neutralizing antibodies and vaccine development. The prefusion conformation is thought to be the optimal vaccine antigen, but previously described prefusion F proteins expressed poorly and were not well stabilized. Here, we use structures of hMPV F to guide the design of 42 variants containing stabilizing substitutions. Through combinatorial addition of disulfide bonds, cavity-filling substitutions, and improved electrostatic interactions, we describe a prefusion-stabilized F protein (DS-CavEs2) that expresses at 15 mg/L and has a melting temperature of 71.9 °C. Crystal structures of two prefusion-stabilized hMPV F variants reveal that antigenic surfaces are largely unperturbed. Importantly, immunization of mice with DS-CavEs2 elicits significantly higher neutralizing antibody titers against hMPV A1 and B1 viruses than postfusion F. The improved properties of DS-CavEs2 will advance the development of hMPV vaccines and the isolation of therapeutic antibodies.

Highlights

  • The human metapneumovirus fusion (F) protein is essential for viral entry and is a key target of neutralizing antibodies and vaccine development

  • HMPV F0 is cleaved by trypsin-like extracellular serine proteases, such as TMPRSS2, the extent to which this occurs in the producing cells versus target cells is not well defined[6]

  • We set out to design variants based on the prefusion (PDB ID: 5WB0) and postfusion (PDB ID: 5L1X) structures of human metapneumovirus (hMPV) F, and characterize their expression yield, monodispersity, thermostability, and antigenicity

Read more

Summary

Introduction

The human metapneumovirus (hMPV) fusion (F) protein is essential for viral entry and is a key target of neutralizing antibodies and vaccine development. Three F2/F1 heterodimers associate into a metastable prefusion trimer that constitutes the active form of the protein In cell culture, this proteolytic activation can be accomplished by the addition of trypsin, which cleaves the protein at a monobasic cleavage site[1,4,5]. The metastable prefusion F protein undergoes a substantial conformational change, liberating and extending the fusion peptide into the host-cell membrane. This unstable pre-hairpin intermediate collapses back onto itself to form a highly stable sixhelix bundle composed of a trimer of the N-terminal and. Given its critical role in viral entry, vaccine candidates for hMPV generally include the F protein

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.